Rennes

• Prevention of secondary infections by interferon gamma in ICU-acquired sustained immune-suppression: a randomized trial Recruiting
  2024-516780-93-00 5 2025-07-09 Sustained immunosuppression
• A Study to Evaluate Tobevibart+Elebsiran in Participants with Chronic HDV Infection Not Virologically Suppressed with Bulevirtide Recruiting
  2024-519282-22-00 5 2025-07-09 Chronic Hepatitis D Virus (HDV) Infection
• Efficacy of methylprednisolone pulses in neuroendocrine cells hyperplasia of infancy: an early phase study (CORTICONEHI). Recruiting
  2023-508132-65-00 4 2025-06-30 NEUROENDOCRINE CELLS HYPERPLASIA OF INFANCY
• metastatic colorectal cancer Recruiting
  2023-504831-42-00 5 2025-06-27 patient with colorectal cancer with hepatic metastasis
• A study to understand if sotagliflozin improves symptoms and is safe in people with hypertrophic cardiomyopathy Recruiting
  2024-513869-39-00 5 2025-06-27 Obstructive Cardiomyopathy, Hypertrophic
• First in human, Phase 1a/1b Study of KM-023 in healthy volunteers and Olmsted syndrome patients Recruiting
  2025-521446-20-00 1 2025-06-27 Olmsted syndrome
• Therapeutic effect of Hydroxychloroquine on IgA Nephropathy course - QUIgAN Study Recruiting
  2024-512653-25-00 5 2025-06-26 IgA nephropathy
• A multicentre, randomized, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy and safety of BP1.4979 in adult p … Recruiting
  2024-517996-19-00 4 2025-06-19 Primary premature ejaculation
• A Phase 2 Study evaluating Epcoritamab in subjects with relapsed and refractory primary diffuse large B-cell lymphoma of the CNS treated wit … Recruiting
  2023-505834-84-00 10 2025-06-17 relapsed and refractory primary diffuse large B-cell lymphoma of the C
• A phase 3 multicenter, randomised, prospective, open-label trial of fixed-duration (12 cycles) venetoclax/ obinutuzumab vs. fixed-duration ( … Recruiting
  2023-510294-34-00 5 2025-06-12 small lymphocytic lymphoma (SLL)
• A Multi-center, Double-Blind, Randomized, Two-Arm, Parallel-Group, Placebo Controlled Study to Assess the Efficacy and Safety of ELGN-2112 o … Recruiting
  2024-517101-87-00 5 2025-05-26 Intestinal Malabsorption
• A Multicentric Randomized Double-Blind Phase 3 Trial Evaluating the Efficacy of an Adapted Antibiotherapy in Hurley Stage 2 Active Hidradeni … Recruiting
  2023-505818-16-00 5 2025-05-22 Hurley stage 2 active Hidradenitis Suppurativa
• Long-term study evaluating joint health in people with haemophilia A receiving real-world prophylactic treatment with efanesoctocog alfa Recruiting
  2024-517812-31-00 6 2025-05-21 Haemophilia A
• A Phase 3, Placebo-Controlled Study to Investigate LP352 in Children and Adults With Dravet Syndrome (DS) Recruiting
  2024-514937-39-00 5 2025-05-20 Dravet Syndrome
• MODULO Recruiting
  2024-515793-27-01 5 2025-04-30 HIV
• Evaluation of the benefits of Administering immunosuppressive drugs as Single daily doses over the first Year after liver transplantation Recruiting
  2023-506601-19-00 6 2025-04-15 transplantation
• Study to Compare Axicabtagene Ciloleucel With Standard of Care Therapy as First-line Treatment in Participants With High-risk Large B-cell L … Recruiting
  2022-501489-24-00 5 2025-03-28 First-line treatment of adult subjects with high-risk large B-cell lym
• Efficacy and safety of bezafibrate 400 mg and bezafibrate 200 mg as adjunctive treatments in patients with primary biliary cholangitis and n … Recruiting
  2023-504086-23-00 5 2025-03-27 Subjects with PBC with a non-optimal response to UDCA.
• HALT : Influence of Human Albumin supplementation on kidney dysfunction after Liver Transplantation Recruiting
  2024-514804-14-00 6 2025-03-26 Liver transplantation
• Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant Recruiting
  2024-513547-82-00 5 2025-03-11 Transthyretin Amyloidosis
• MAESTRO-4MS : "Allogenic Adipose tissue-derived Mesenchymal Stromal Cells for the treatment of Primary Progressive Multiple Sclerosis: an op … Recruiting
  2023-509538-20-01 1 2025-03-06 Primary Progressive Multiple Sclerosis
• A phase II, multicenter, open-label study evaluating Glofitamab in combination with Venetoclax plus Zanubrutinib or Venetoclax alone in subj … Recruiting
  2023-506706-40-00 10 2025-02-11 Mantle-Cell Lymphoma
• Beta-blOckers discoNtinuation in patients presenting heart FaIlure with REcovered left ventricular ejection fraction Recruiting
  2023-508798-94-00 5 2025-02-11 Heart failure
• A Study of Cemiplimab Plus Chemotherapy Versus Cemiplimab Plus Chemotherapy Plus Other Cancer Treatments for Adult Patients with Operable No … Recruiting
  2023-509806-31-00 4 2025-02-11 Non-Small Cell Lung Cancer

Showing 145–168 of 519 trials